Internet-delivered Cognitive Behavior Therapy Compared to Stress Management for Atrial Fibrillation
1 other identifier
interventional
206
1 country
1
Brief Summary
The aim of this study is to evaluate if internet- delivered cognitive behavior therapy (CBT), based on exposure principles and behavioral activation, improves QoL and symptom burden in patients with symptomatic atrial fibrillation (AF), controlling for expectancy of improvement and attention from a caregiver, using an active control group (stress management). The study will include 260 patients with symptomatic AF despite optimal medical treatment in accordance with current guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2021
CompletedFirst Posted
Study publicly available on registry
July 15, 2021
CompletedStudy Start
First participant enrolled
August 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2023
CompletedOctober 11, 2023
October 1, 2023
1.6 years
June 24, 2021
October 10, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Atrial Fibrillation Effect on Quality-of-Life modified for weekly assessment
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction. Total score ranges from 0 (severe symptoms and disability) to 100 (no symptoms and disability).
Change over 11 measurement points measured from baseline and weekly for 10 weeks during treatment [PRIMARY ENDPOINT]
Atrial Fibrillation Effect on Quality-of-Life modified for weekly assessment
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction. Total score ranges from 0 (severe symptoms and disability) to 100 (no symptoms and disability).
From baseline to 9 months
Secondary Outcomes (30)
Cardiac Anxiety Questionnaire (CAQ)
From baseline to 10 weeks
Cardiac Anxiety Questionnaire (CAQ)
From baseline to 9 months
AF-avoidance behavior questionnaire
From baseline to 10 weeks
AF-avoidance behavior questionnaire
From baseline to 9 months
AF-avoidance behavior questionnaire modified for weekly assessment
Change over 11 measurement points measured from baseline and weekly for 10 weeks during treatment
- +25 more secondary outcomes
Other Outcomes (7)
Psychosocial stressors and changes in physical health
10 weeks from baseline
Psychosocial stressors and changes in physical health
9 months from baseline
Background data
Baseline
- +4 more other outcomes
Study Arms (2)
Internet-delivered exposure-focused CBT
EXPERIMENTALInternet-delivered CBT over 10 weeks The CBT treatment lasts for 10 weeks and includes the following: Education on the role of anxiety on cardiac function and the effects of symptom preoccupation and avoidance QoL and depression in AF, creating a vicious cycle; exposure to physical sensations that are similar to AF symptoms (e.g.,palpitations due to physical activity or stress) to reduce fear of these symptoms; exposure to situations or activities previously avoided and abolishment of behaviors that aim to control symptoms; and behavioral activation aiming to increase social and physical activity and reduce depressive symptoms. Therapist support is provided at least once weekly through the platform developed for the purpose. Therapists are trained CBT-psychologists.
Internet-delivered stress management treatment
ACTIVE COMPARATORStress management treatment for 10 weeks Participants randomized to The Stress Management Treatment will receive 10 weeks of stress managemen including relaxation technics, standard life style advice regarding physical activity, sleep and and standardized AF-information in line with current guidelines for AF. Therapist support is provided at least once weekly through the platform developed for the purpose. Therapists are trained CBT-psychologists.
Interventions
The intervention lasts for 10 weeks and include: Education, Interoceptive exposure, exposure in-vivo, combining in-vivo exposure with interoceptive exposure, behavioral activation and relapse prevention. Include the guidance of a minimum weekly contact with a CBT psychologist.
The intervention last for 10 weeks and include: Internet-SMT include life-style advice (e.g., exercise, sleep advice), relaxation and problem-solving skills to reduce stress. Patients are offered regular online contact with a psychologist with the same frequency and intensity as in the CBT arm.
Eligibility Criteria
You may qualify if:
- Paroxysmal AF ≥ once per month that causes moderate to severe symptoms and leads to significant distress or interferes with daily life (i.e. EHRA class ≥ IIb);
- Scoring ≥ 20 on the Cardiac Anxiety Questionnaire at screening;
- Age 18-75 years;
- On optimal medical treatment;
- Able to read and write in Swedish.
You may not qualify if:
- Heart failure with severe systolic dysfunction (ejection fraction ≤ 35%);
- Significant valvular disease;
- Planned ablation for AF or ablation within 3 months before assessment;
- Other severe medical illness;
- Any medical restriction to physical exercise;
- Severe psychiatric disorder, severe depression, or risk of suicide;
- Alcohol dependency;
- Previous participation in any AF-CBT study conducted by the research group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Karolinska University Hospitalcollaborator
Study Sites (1)
Karolinska universitetssjukhuset Solna
Solna, 171 64, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brjann Ljotsson, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor,PhD, Lic. psychologist
Study Record Dates
First Submitted
June 24, 2021
First Posted
July 15, 2021
Study Start
August 13, 2021
Primary Completion
March 31, 2023
Study Completion
October 5, 2023
Last Updated
October 11, 2023
Record last verified: 2023-10